Docs offer varied cures for ailing health care system
Indianapolis physicians are mixed on the merits of a government-run, "public" health insurance plan. How reforms
might affect their pay is another major concern.
Indianapolis physicians are mixed on the merits of a government-run, "public" health insurance plan. How reforms
might affect their pay is another major concern.
Industry groups in the life sciences, medical and information technology realms have helped lure companies to the region
and foster upstarts. Funding is almost always an issue, but it’s not the only barrier. Getting medical
devices to market often requires product design, development and marketing resources that aren’t
always apparent to upstarts.
The Indianapolis-based forensics, clinical and pharmaceutical testing firm now ranks 598, up from 1,466 a year ago. The list
is based on percentage of revenue growth.
With the Obama administration backing away from a government-run, "public" plan, the insurance
industry faces a much smaller threat in the form of privately run insurance co-ops.
Indianapolis-based startup My Health Care Manager has signed an agreement with Indianapolis-based
WellPoint Inc. that will eventually put My Health Care Manager’s elder care service in front of the health insurer’s
thousands of employer clients and their workers around the country.
Indianapolis-based Monarch Beverage is among hundreds of central Indiana companies that
have introduced wellness programs to counteract the rising costs of health insurance and Worker’s Compensation.
It’s no secret that Eli Lilly and Co. is the biggest private employer in the Indianapolis area. But
Lilly also supplemented the incomes of a few dozen local doctors — to the tune of more than $224,000 in just the first
quarter.
Safeco is leaving a five-building complex on North Meridian Street, and Eli Lilly and Co. has offered for lease its entire
four-building Faris campus.
In almost every place that two or more Americans gather, health care is debated. Because the bills before Congress are
inaccessible, the debate has shifted instead to principles such as the role of government and individual freedoms. I think this a healthy thing.
For a city feverishly growing its technology and life sciences sectors, it seemed a bit anticlimactic last January when
Purdue University dedicated its new technology center with only one tenant. But the lone tenant in the $12.8
million complex, FlamencoNets, a high-tech telecommunications firm, is about to get some company.
The Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
Eli Lilly and Co. has reorganized its venture capital division and simultaneously poured in an additional $25 million.
Hill-Rom Holdings Inc. topped analysts’ expectations in its fiscal third
quarter even as hospital-spending cuts clipped its revenue by 9 percent, the company announced late yesterday.
If one of the more liberal health care reform proposals becomes law, Hoosier taxpayers would have to spend $425 more per
person every year for the next decade, according to a study released Aug. 4 by Florida-based conservative policy group Arduin
Laffer & Moore Econometrics.
In the eyes of Scott Law, Congress is heading in exactly the wrong direction on health care reform.
But the
CEO of Zotec Partners predicts a big bump in sales for his physician-billing management company if current reform proposals
become law.
A panel of five leaders of the state’s life sciences
industry took on a wide range of topics
July 24 at IBJ’s Power Breakfast
at the Westin Indianapolis.
More emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
Conseco Inc. recorded profit at the high-end of its preliminary
estimates, the company announced today.
Indianapolis-based Eli Lilly and Co. today said it is offering buyouts to its U.S. sales force,
with hopes of trimming about 300 sales representatives before a sales restructuring set to begin in January, Reuters reported.
Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But
chances that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit appear to have decreased.